EUCTR2007-002365-13-NL进行中（未招募）1 期
Sorafenib as adjuvant to radioiodine therapy in non-medullary thyroid carcinoma
Bayer B.V.0 个研究点目标入组 0 人开始时间: 2007年5月11日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •·Patients with non-medullary thyroid carcinoma
- •·The patients must have undergone total thyroidectomy
- •·Presence of metastases or inoperable recurrent disease, as proven by elevated serum thyroglobulin levels (Tg) in combination with radiological evidence for tumor.
- •·No or insufficient RaI uptake in tumor as proven by RaI scintigraphy, performed after prior RaI therapy.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •·Other active malignancies
- •·Active kidney, liver or pancreatic disease or dysfunction
- •·Unstable angina pectoris or recent (<3 months) myocardial infarction.
- •·Coagulopathy
研究者
相似试验
尚未招募
2 期
Sorafenib as adjuvant to radioiodine therapy in non-medullary thyroid carcinomathyroid carcinoma1005254710014713NL-OMON31009Academisch Medisch Centrum30
已完成
2 期
Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid CarcinomaThyroid CancerNCT00887107Leiden University Medical Center32
已完成
不适用
Study of sorafenib and radiation therapy for advanced hepatocellular carcinoma with portal vein thrombosisadvanced hepatocellular carcinomaJPRN-UMIN000008184Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine6
已完成
1 期
Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients With Soft Tissue Sarcoma of the Extremity and Body WallSoft Tissue SarcomaNCT00864032University of California, Davis8
进行中（未招募）
不适用
Sorafenib in the first line treatment of advanced hepatocellular carcinoma with ChildPugh liver function class B. Multicentre phase 3 randomized trial - BOOSTadvanced hepatocellular carcinoma with ChildPugh liver function class BMedDRA version: 9.1Level: LLTClassification code 10024720EUCTR2009-013870-42-ITISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI - FONDAZIONE G. PASCALE